產品中心
當前位置:首頁
產品中心
抗體/抗原
Biosimilar抗體
S0B1436Anti-human Claudin 18.2 Monoclonal Antibody (zolbetuximab)

產品型號:S0B1436
更新時間:2025-10-11
廠商性質:生產廠家
訪問量:191
服務熱線15855403091
相關文章
Claudin 18.2 monoclonal antibodies are a promising class of therapeutic agents targeting the Claudin 18.2 protein, a tight junction protein that is highly expressed in various cancers, including gastric, pancreatic, and ovarian cancers. In normal tissues, Claudin 18.2 is predominantly expressed in differentiated gastric mucosal cells, but its upregulation in tumor cells makes it an attractive target for cancer therapy. These monoclonal antibodies, such as Zolbetuximab, work by binding specifically to the extracellular domain of Claudin 18.2, inducing antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) to kill cancer cells.